Hims & Hers Health (Hims & Hers Health) GF Value : $13.45 (As of May. 05, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Hims & Hers Health GF Value?

The GF Value represents the current intrinsic value of a stock derived from our exclusive method. The GF Value Line on our summary page gives an overview of the fair value that the stock should be traded at. It is calculated based on three factors:

Historical multiples (PE Ratio, PS Ratio, PB Ratio and Price-to-Free-Cash-Flow) that the stock has traded at.
GuruFocus adjustment factor based on the company’s past returns and growth.
Future estimates of the business performance.

We believe the GF Value Line is the fair value that the stock should be traded at. The stock price will most likely fluctuate around the GF Value Line. If the stock price is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher.

Please note, "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

As of today (2024-05-05), Hims & Hers Health's share price is $11.26. Hims & Hers Health's GF Value is $13.45. Therefore, Hims & Hers Health's Price-to-GF-Value for today is 0.84.

Based on the relationship between the current stock price and the GF Value, GuruFocus believes Hims & Hers Health is Modestly Undervalued.

Hims & Hers Health (NYSE:HIMS) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 evaluations:

Posssible Evaluations	All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)	Predictable Companies that possibly be Value Traps
Significantly Overvalued	Predictable Companies which are Significantly Overvalued
Modestly Overvalued	Predictable Companies which are Modestly Overvalued
Fairly Valued	Predictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)	Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)	Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) There is only a sufficient margin of safety when the stock is undervalued.

Hims & Hers Health's Price-to-GF-Value for today is calculated as

Price-to-GF-Value	=	Share Price	/	GF Value
	=	11.26	/	13.45
	=	0.84

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hims & Hers Health GF Value Related Terms

Thank you for viewing the detailed overview of Hims & Hers Health's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Hims & Hers Health (Hims & Hers Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Hims & Hers Health Inc (NYSE:HIMS) » Definitions » GF Value

Comparable Companies

Traded in Other Exchanges

82W:Germany

Address

2269 Chestnut Street, Suite 523, San Francisco, CA, USA, 94123

Website

https://www.forhims.com

Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, primary care, and more.

Executives

Andrew Dudum	director, 10 percent owner, officer: Chief Executive Officer	2269 CHESTNUT STREET, #523, SAN FRANCISCO CA 94123
Oluyemi Okupe	officer: Chief Financial Officer	2269 CHESTNUT ST., #523, SAN FRANCISCO CA 94123
Soleil Boughton	officer: See Remarks	2269 CHESTNUT STREET, #523, SAN FRANCISCO CA 94123
Lynne Chou O'keefe	director	2269 CHESTNUT STREET, #523, SAN FRANCISCO CA 94123
Irene Becklund	officer: Interim PFO/PAO	2269 CHESTNUT ST., #523, SAN FRANCISCO CA 94123
Melissa Baird	officer: Chief Operating Officer	2269 CHESTNUT STREET, #523, SAN FRANCISCO CA 94123
David B Wells	director	C/O NETFLIX, INC., 100 WINCHESTER CIRCLE, LOS GATOS CA 95130
Alex Bard	director	2269 CHESTNUT STREET, #523, SAN FRANCISCO CA 94123
Ivp Executive Fund Xvi, Llc	10 percent owner	3000 SAND HILL ROAD, BUILDING 2, SUITE 2, MENLO PARK CA 94025
Jules A. Maltz	director	3000 SAND HILL ROAD, BUILDING 2, SUITE 250, MENLO PARK CA 94025
Christiane Pendarvis	director	2269 CHESTNUT ST., #523, SAN FRANCISCO CA 94123
Michael Chi	officer: Chief Marketing Officer	2269 CHESTNUT ST., #523, SAN FRANCISCO CA 94123
Somesh Dash	10 percent owner	3000 SAND HILL ROAD, BUILDING 2, SUITE 250, MENLO PARK CA 94025
Jack Abraham	10 percent owner	1 LETTERMAN DRIVE, SUITE C3500, SAN FRANCISCO CA 94129
Patrick Harrison Carroll	officer: Chief Medicall Officer	2269 CHESTNUT STREET, # 523, SAN FRANCISCO CA 94123